Clinical Trials Browser

Phase 2 × Active not recruiting × Hydroxyurea × Clear all

NCT05020652 2025-12-17

A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis

Phase 2 Active not recruiting

Lymphoma, Follicular